Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2012 1
2013 1
2014 2
2015 1
2016 1
2020 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, Della Peruta M, Lheriteau E, Patel N, Raj D, Riddell A, Pie J, Rangarajan S, Bevan D, Recht M, Shen YM, Halka KG, Basner-Tschakarjan E, Mingozzi F, High KA, Allay J, Kay MA, Ng CY, Zhou J, Cancio M, Morton CL, Gray JT, Srivastava D, Nienhuis AW, Davidoff AM. Nathwani AC, et al. Among authors: lheriteau e. N Engl J Med. 2014 Nov 20;371(21):1994-2004. doi: 10.1056/NEJMoa1407309. N Engl J Med. 2014. PMID: 25409372 Free PMC article. Clinical Trial.
Haemophilia gene therapy: Progress and challenges.
Lheriteau E, Davidoff AM, Nathwani AC. Lheriteau E, et al. Blood Rev. 2015 Sep;29(5):321-8. doi: 10.1016/j.blre.2015.03.002. Epub 2015 Mar 26. Blood Rev. 2015. PMID: 26049173 Review.
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.
Vanhove B, Duvaux O, Rousse J, Royer PJ, Evanno G, Ciron C, Lheriteau E, Vacher L, Gervois N, Oger R, Jacques Y, Conchon S, Salama A, Duchi R, Lagutina I, Perota A, Delahaut P, Ledure M, Paulus M, So RT, Mok CK, Bruzzone R, Bouillet M, Brouard S, Cozzi E, Galli C, Blanchard D, Bach JM, Soulillou JP. Vanhove B, et al. Among authors: lheriteau e. Eur J Immunol. 2021 Jun;51(6):1412-1422. doi: 10.1002/eji.202049072. Epub 2021 Mar 2. Eur J Immunol. 2021. PMID: 33576494 Free PMC article.
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.
Vanhove B, Duvaux O, Rousse J, Royer PJ, Evanno G, Ciron C, Lheriteau E, Vacher L, Gervois N, Oger R, Jacques Y, Conchon S, Salama A, Duchi R, Lagutina I, Perota A, Delahaut P, Ledure M, Paulus M, So RT, Mok CK, Bruzzone R, Bouillet M, Brouard S, Cozzi E, Galli C, Blanchard D, Bach JM, Soulillou JP. Vanhove B, et al. Among authors: lheriteau e. bioRxiv [Preprint]. 2020 Oct 28:2020.07.25.217158. doi: 10.1101/2020.07.25.217158. bioRxiv. 2020. PMID: 34013271 Free PMC article. Updated. Preprint.
LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation.
Rousse J, Royer PJ, Evanno G, Lheriteau E, Ciron C, Salama A, Shneiker F, Duchi R, Perota A, Galli C, Cozzi E, Blancho G, Duvaux O, Brouard S, Soulillou JP, Bach JM, Vanhove B. Rousse J, et al. Among authors: lheriteau e. Front Immunol. 2023 Feb 16;14:1137629. doi: 10.3389/fimmu.2023.1137629. eCollection 2023. Front Immunol. 2023. PMID: 36875084 Free PMC article.
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.
Vanhove B, Marot S, So RT, Gaborit B, Evanno G, Malet I, Lafrogne G, Mevel E, Ciron C, Royer PJ, Lheriteau E, Raffi F, Bruzzone R, Mok CKP, Duvaux O, Marcelin AG, Calvez V. Vanhove B, et al. Among authors: lheriteau e. Front Immunol. 2023 Apr 28;14:1208705. doi: 10.3389/fimmu.2023.1208705. eCollection 2023. Front Immunol. 2023. PMID: 37187748 Free PMC article.
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.
Vanhove B, Marot S, So RT, Gaborit B, Evanno G, Malet I, Lafrogne G, Mevel E, Ciron C, Royer PJ, Lheriteau E, Raffi F, Bruzzone R, Mok CKP, Duvaux O, Marcelin AG, Calvez V. Vanhove B, et al. Among authors: lheriteau e. Front Immunol. 2021 Nov 15;12:761250. doi: 10.3389/fimmu.2021.761250. eCollection 2021. Front Immunol. 2021. PMID: 34868003 Free PMC article.
Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy.
Lhériteau E, Petit L, Weber M, Le Meur G, Deschamps JY, Libeau L, Mendes-Madeira A, Guihal C, François A, Guyon R, Provost N, Lemoine F, Papal S, El-Amraoui A, Colle MA, Moullier P, Rolling F. Lhériteau E, et al. Mol Ther. 2014 Feb;22(2):265-277. doi: 10.1038/mt.2013.232. Epub 2013 Oct 4. Mol Ther. 2014. PMID: 24091916 Free PMC article.
The RPGRIP1-deficient dog, a promising canine model for gene therapy.
Lhériteau E, Libeau L, Stieger K, Deschamps JY, Mendes-Madeira A, Provost N, Lemoine F, Mellersh C, Ellinwood NM, Cherel Y, Moullier P, Rolling F. Lhériteau E, et al. Mol Vis. 2009;15:349-61. Epub 2009 Feb 18. Mol Vis. 2009. PMID: 19223988 Free PMC article.
13 results